Clinical Trial Management System Market Size, Share, and Analysis, By Type (Enterprise CTMS, On-Site CTMS), By Component (Software, Services), By Mode of Delivery (Cloud-Based CTMS, Web-Based CTMS, On-Premise CTMS), By End User (Pharmaceuticals, Clinical Research Organizations [CROs], Healthcare Providers), and Regional Forecasts, 2022-2032

November 2023 | 330 pages | ID: C0D9DA05E021EN
Fatpos Global

Abstracts

Clinical Trial Management System Market Size, Share, and Analysis, By Type (Enterprise CTMS, On-Site CTMS), By Component (Software, Services), By Mode of Delivery (Cloud-Based CTMS, Web-Based CTMS, On-Premise CTMS), By End User (Pharmaceuticals, Clinical Research Organizations [CROs], Healthcare Providers), and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW

Clinical Trial Management System Market size was USD 1.26 billion in 2021 and projected t%li%grow from USD 1.6 billion in 2023 t%li%USD 5.0 billion by 2032, exhibiting a CAGR of 13.3% during the forecast period.

A CTMS software system, elaborated as Clinical Trial Management System manages all the activities associated with the arrangement, conduction, and wrap-up of clinical trials like planning, arrangement, monitoring, tracking, compliance, along with reporting. Precisely, the necessary set of tools for efficiently planning, managing, and tracking your clinical research portfoli%li%is CTMS. It is a specified, complete application of project management that guides the study team from the beginning through enrolment and supervision, t%li%study closure.

MARKET HIGHLIGHTS

Clinical Trial Management System market is expected t%li%reach USD 5.0 billion, growing at a CAGR of 13.3% during the forecast period owing t%li%healthcare IT's quick development, the inclination for decentralized clinical trials, business activities by important corporations, and an increase in clinical studies. Also, the need t%li%develop vaccines during the coronavirus pandemic als%li%boosted the adoption of decentralized clinical trials, which fuelled the market growth.

Clinical Trial Management System Market Segments:

• Type
• Enterprise CTMS
• On-Site CTMS
• Component
• Software
• Services
• Mode of Delivery
• Cloud-Based CTMS
• Web-Based CTMS
• On-Premise CTMS
• End User
• Pharmaceuticals
• Clinical Research Organizations (CROs)
• Healthcare Providers

MARKET DYNAMICS

Growth Drivers

Growing Number of Clinical Trials & Rising Cases of Rare and Chronic Diseases are Expected t%li%Boost the Market Growth

Rising Technological Advancements in Software and Hardware are Expected t%li%Boost the Market Growth

Restraint

Costly Clinical Trials and Expensive Clinical Trial Management Systems t%li%Restrain the Market Growth

Key Players

• Wipr%li%Limited
• Oracle
• Labcorp
• IQVIA Inc.
• Parexel International Corporation
• Veeva Systems
• Medidata
• Calyx
• Advarra Inc.
• Clario
• MasterControl Inc.
• DATATRAK International Inc.
• RealTime Software Solutions LLC
• SimpleTrials
• PHARMASEAL International Ltd.
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons t%li%Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight int%li%the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
• 3-month post-sales analyst support.

Contents

1. EXECUTIVE SUMMARY

1. REGIONAL MARKET SHARE

2. BUSINESS TRENDS

3. CLINICAL TRIAL MANAGEMENT SYSTEM MARKET: COVID-19 OUTBREAK

4. REGIONAL TRENDS

5. SEGMENTATION SNAPSHOT

2. RESEARCH METHODOLOGY

1. RESEARCH OBJECTIVE

2. RESEARCH APPROACH

3. DATA SOURCING AND METHODOLOGY

4. PRIMARY RESEARCH

5. SECONDARY RESEARCH

1. PAID SOURCES

2. PUBLIC SOURCES

6. MARKET SIZE ESTIMATION AND DATA TRIANGULATION

3. MARKET CHARACTERISTICS

1. MARKET DEFINITION

2. CLINICAL TRIAL MANAGEMENT SYSTEM MARKET: COVID-19 IMPACT

3. KEY SEGMENTATIONS

4. KEY DEVELOPMENTS

5. ALLIED INDUSTRY DATA

4. CLINICAL TRIAL MANAGEMENT SYSTEM MARKET – INDUSTRY INSIGHTS

1. INDUSTRY SEGMENTATION

2. COVID-19 OVERVIEW ON WORLD ECONOMY.

3. INDUSTRY ECOSYSTEM CHANNEL ANALYSIS

4. INNOVATION & SUSTAINABILITY

5. MACROECONOMIC INDICATORS

6. RECENT DEVELOPMENTS

7. MARKET DYNAMICS

1. INTRODUCTION

2. GROWTH DRIVERS

3. MARKET OPPORTUNITIES

4. MARKET RESTRAINTS

5. MARKET TRENDS

8. MARKET ANALYSIS

1. PORTERS FIVE FORCES

2. PEST ANALYSIS

1. POLITICAL

2. ECONOMIC

3. SOCIAL

4. TECHNOLOGICAL

9. CLINICAL TRIAL MANAGEMENT SYSTEM MARKET

1. OVERVIEW

2. HISTORICAL ANALYSIS (2016-2021)

1. MARKET SIZE, Y-O-Y GROWTH (%) AND MARKET FORECAST

10. CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SIZE & FORECAST 2022A-2032F

1. OVERVIEW

2. KEY FINDINGS

3. MARKET SEGMENTATION

1. BY TYPE

1. ENTERPRISE CTMS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

2. ON-SITE CTMS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

2. BY COMPONENT

1. SOFTWARE

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

2. SERVICES

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

3. BY MODE OF DELIVERY

1. CLOUD-BASED CTMS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

2. WEB-BASED CTMS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

3. ON-PREMISE CTMS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

4. BY END USER

1. PHARMACEUTICALS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

2. CLINICAL RESEARCH ORGANIZATIONS (CROS)

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

3. HEALTHCARE PROVIDERS

1. BY VALUE (USD MILLION) 2022-2032F

2. MARKET SHARE (%) 2022-2032F

3. Y-O-Y GROWTH (%) 2022-2032F

11. NORTH AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SIZE & FORECAST 2022A-2032F

1. OVERVIEW

2. KEY FINDINGS

3. MARKET SEGMENTATION

1. BY TYPE

2. BY COMPONENT

3. BY MODE OF DELIVERY

4. BY END USER

4. COUNTRY

1. UNITED STATES

2. CANADA

12. EUROPE CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SIZE & FORECAST 2022A-2032F

1. OVERVIEW

2. KEY FINDINGS

3. MARKET SEGMENTATION

1. BY TYPE

2. BY COMPONENT

3. BY MODE OF DELIVERY

4. BY END USER

4. COUNTRY

1. GERMANY

2. UNITED KINGDOM

3. FRANCE

4. ITALY

5. SPAIN

6. RUSSIA

7. REST OF EUROPE (BENELUX, NORDIC, HUNGARY, TURKEY & POLAND)

13. ASIA CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SIZE & FORECAST 2022A-2032F

1. OVERVIEW

2. KEY FINDINGS

3. MARKET SEGMENTATION

1. BY TYPE

2. BY COMPONENT

3. BY MODE OF DELIVERY

4. BY END USER

4. COUNTRY

1. INDIA

2. CHINA

3. SOUTH KOREA

4. JAPAN

5. REST OF APAC

14. MIDDLE EAST AND AFRICA CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SIZE & FORECAST 2022A-2032F

1. OVERVIEW

2. KEY FINDINGS

3. MARKET SEGMENTATION

1. BY TYPE

2. BY COMPONENT

3. BY MODE OF DELIVERY

4. BY END USER

4. COUNTRY

1. ISRAEL

2. GCC

3. NORTH AFRICA

4. SOUTH AFRICA

5. REST OF MIDDLE EAST AND AFRICA

15. LATIN AMERICA CLINICAL TRIAL MANAGEMENT SYSTEM MARKET SIZE & FORECAST 2022A-2032F

1. OVERVIEW

2. KEY FINDINGS

3. MARKET SEGMENTATION

1. BY TYPE

2. BY COMPONENT

3. BY MODE OF DELIVERY

4. BY END USER

4. COUNTRY

1. MEXICO

2. BRAZIL

3. REST OF LATIN AMERICA

16. COMPETITIVE LANDSCAPE

1. COMPANY MARKET SHARE, 2021

2. KEY PLAYER OVERVIEW

3. KEY STAKEHOLDERS

17. COMPANY PROFILES

1. WIPRO LIMITED

1. COMPANY OVERVIEW

2. FINANCIAL OVERVIEW

3. KEY PRODUCT; ANALYSIS

4. COMPANY ASSESSMENT

1. PRODUCT PORTFOLIO

2. KEY CLIENTS

3. MARKET SHARE

4. RECENT NEWS & DEVELOPMENT (LAST 3 YRS.)

5. EXECUTIVE TEAM

2. ORACLE

3. LABCORP

4. IQVIA INC.

5. PAREXEL INTERNATIONAL CORPORATION

6. VEEVA SYSTEMS

7. MEDIDATA

8. CALYX

9. ADVARRA INC.

10. CLARIO

11. MASTERCONTROL INC.

12. DATATRAK INTERNATIONAL INC.

13. REALTIME SOFTWARE SOLUTIONS LLC

14. SIMPLETRIALS

15. PHARMASEAL INTERNATIONAL LTD.

16. OTHER PROMINENT PLAYERS

18. APPENDIX

19. CONSULTANT RECOMMENDATION